Evidence map›Paper›PMID 22685405›Full record

ArticlePLoS pathogens2012

Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry.

Young Bong Choi, Gordon Sandford, John Nicholas

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Kaposi sarcoma herpesvirus pathogenesis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  12. Article
  13. Article
  14. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2014
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Young Bong ChoiSidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Gordon Sandford
John Nicholas
Sidney Kimmel Comprehensive Cancer Center · USJohns Hopkins University · US

Funding

Role of KSHV in AIDS MalignanciesP01CA113239 · NCI · JOHNS HOPKINS UNIVERSITY · PI NICHOLAS, JOHN · 2006 to 2010
$5.8M
Mitochondrial-localized activities of HHV-8 vIRF-1R21AI099655 · NIAID · JOHNS HOPKINS UNIVERSITY · PI NICHOLAS, JOHN · 2012 to 2013
$451k
Bim regulation by HHV-8 vIRF-1R21CA136356 · NCI · JOHNS HOPKINS UNIVERSITY · PI NICHOLAS, JOHN · 2008 to 2009
$406k
NCI NIH HHS CA113239NCI NIH HHS CA136356NCI NIH HHS P01 CA113239NCI NIH HHS R21 CA136356NIAID NIH HHS AI099655NIAID NIH HHS R21 AI099655
6 · The paper itself

Abstract

Viral replication efficiency is in large part governed by the ability of viruses to counteract pro-apoptotic signals induced by infection of host cells. For HHV-8, viral interferon regulatory factor-1 (vIRF-1) contributes to this process in part via inhibitory interactions with BH3-only protein (BOP) Bim, recently identified as an interaction partner of vIRF-1. Here we recognize that the Bim-binding domain (BBD) of vIRF-1 resembles a region (BH3-B) of Bid, another BOP, which interacts intramolecularly with the functional BH3 domain of Bid to inhibit it pro-apoptotic activity. Indeed, vIRF-1 was found to target Bid in addition to Bim and to interact, via its BBD region, with the BH3 domain of each. In functional assays, BBD could substitute for BH3-B in the context of Bid, to suppress Bid-induced apoptosis in a BH3-binding-dependent manner, and vIRF-1 was able to protect transfected cells from apoptosis induced by Bid. While vIRF-1 can mediate nuclear sequestration of Bim, this was not the case for Bid, and inhibition of Bid and Bim by vIRF-1 could occur independently of nuclear localization of the viral protein. Consistent with this finding, direct BBD-dependent inactivation by vIRF-1 of Bid-induced mitochondrial permeabilization was demonstrable in vitro and isolated BBD sequences were also active in this assay. In addition to Bim and Bid BH3 domains, BH3s of BOPs Bik, Bmf, Hrk, and Noxa also were found to bind BBD, while those of both pro- and anti-apoptotic multi-BH domain Bcl-2 proteins were not. Finally, the significance of Bid to virus replication was demonstrated via Bid-depletion in HHV-8 infected cells, which enhanced virus production. Together, our data demonstrate and characterize BH3 targeting and associated inhibition of BOP pro-apoptotic activity by vIRF-1 via Bid BH3-B mimicry, identifying a novel mechanism of viral evasion from host cell defenses.

Indexed as

Immune EvasionMolecular MimicryAmino Acid SequenceApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11BH3 Interacting Domain Death Agonist ProteinCell LineFluorescent Antibody TechniqueHerpesviridae InfectionsHerpesvirus 8, HumanHumansImmunoblottingImmunoprecipitationIn Situ Nick-End LabelingInterferon Regulatory FactorsApoptosis Regulatory ProteinsBCL2L11 protein, humanBcl-2-Like Protein 11BH3 Interacting Domain Death Agonist ProteinBID protein, humanInterferon Regulatory FactorsMembrane ProteinsProto-Oncogene Proteinsviral interferon regulatory factorsViral Proteins

Identifiers

PMID22685405
PMCPMC3369933
OpenAlexW2002206042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.